Recursion Pharmaceuticals (RXRX) Tax Rate (2023 - 2026)

Recursion Pharmaceuticals' Tax Rate history runs 4 years deep, the most recent figure standing at 3.77% for Q1 2026.

• Quarterly Tax Rate rose 369.0% year-over-year to 3.77% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.81% (up 72.0% YoY) and the FY2025 annual result came in at 0.02%, down 22.0% from the prior year.
• Tax Rate was 3.77% for Q1 2026 at Recursion Pharmaceuticals, up from 0.02% in the prior quarter.
• Across five years, Tax Rate topped out at 4.19% in Q4 2023 and bottomed at 0.17% in Q3 2024.
• A 4-year average of 1.02% and a median of 0.08% in 2025 frame the typical range for Tax Rate.
• Annual changes were most pronounced in 2024 — Tax Rate sank 419 bps — and 2026, when it surged 369 bps.
• Recursion Pharmaceuticals' Tax Rate stood at 4.19% in 2023, then tumbled by 100 bps to 0.0% in 2024, then tumbled by 373 bps to 0.02% in 2025, then surged by 20480 bps to 3.77% in 2026.
• Business Quant data shows RXRX's Tax Rate at 3.77% in Q1 2026, 0.02% in Q4 2025, and 0.0% in Q3 2025.